CHE
CHEMED CORP
NYSE · Healthcare · Medical - Care Facilities · US
$504.06
−0.38%Year over year
Reported trailing growth
- Revenue
- +3.3%
- EBITDA
- -4.8%
- EBIT
- -5.3%
- EPS
- +1.5%
- Free cash flow
- -12.9%
- Operating cash flow
- -8.6%
Forward estimates
Based on analyst estimates
- Revenue
- +8.0%
- EBITDA
- +21.8%
- EPS
- +29.1%
Three-year CAGR
- Revenue
- +5.8%
- EBITDA
- +2.4%
- EBIT
- -0.5%
- Net income
- +2.0%
- EPS
- +3.3%
- Free cash flow
- +8.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026